An Investigation Has Commenced on Behalf of Harmony Biosciences Holdings, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your HRMY Losses.
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. for potential federal securities law violations. This follows a report by Scorpion Capital raising concerns about Harmony's narcolepsy drug, Wakix.
November 13, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Harmony Biosciences is under investigation for potential securities law violations related to its narcolepsy drug, Wakix, following a critical report by Scorpion Capital.
The investigation by Levi & Korsinsky into Harmony Biosciences for potential securities law violations is significant. The concerns raised by Scorpion Capital about Wakix could lead to legal and regulatory challenges, potentially impacting HRMY's stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100